Johnson & Johnson announced it will convert two 340B drugs to a rebate model for hospitals.

J&J Announces Plans to Shift Certain 340B Discounts to Rebate Model, Prompting Fierce Backlash from Providers, Regulators

August 23, 2024 William Newton, Associate Editor/Senior Writer Views

In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!